Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Idexx Laboratories (NASDAQ: IDXX) today and set a price target of $260. The company’s shares closed yesterday at $229.51, close to its 52-week high of $229.98.
According to TipRanks.com, Block is a 5-star analyst with an average return of 23.3% and a 76.0% success rate. Block covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA Inc, Align Tech, and Hologic.
Currently, the analyst consensus on Idexx Laboratories is a Strong Buy with an average price target of $232.
See today’s analyst top recommended stocks >>
The company has a one-year high of $229.98 and a one-year low of $146.09. Currently, Idexx Laboratories has an average volume of 432.2K.
Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.
